SFAsia Webinar Singapore: Biotech

Join us for a conversation on the policies that support the establishment of your biotech business in San Francisco.

Over the past six years, SFAsia has developed a network of partnerships with a wide range of diverse partners from every sector of the economy, including major corporations, startups, NGOs,  state and local governments, and international export agencies. One of these important partnerships - Enterprise  Singapore – will be showcased in a webinar focused on the biotech industry on May 25. 

While the San Francisco Bay Area is the premier destination in the world for biotech investment, the very size and complexity of the industry can make it difficult to navigate. This discussion will provide background on the emergence of biotech and its associated ecosystem here in the Bay Area. It will particularly be designed to address business opportunities in the biotech industry, informing startups on what they should expect as they look to launch their businesses in this region.

Speakers include:

• Mark Chandler, Director, San Francisco Mayor’s Office of International Trade & Commerce 

• N Bruce Pickering, Ph.D., Senior Policy Advisor, GlobalSF

• Delon Toh, Regional Director (US Midwest and Western Canada) | Americas and Europe, Enterprise Singapore

• Jack Challis, Sr. Vice President of US Operations, Lucence Diagnostics

• Jeffrey Lu, CEO, Engine Biosciences

• David Schaffer, PhD, incoming Director of the QB3 biosciences consortium (UC Berkeley, UC San Francisco and UC Santa Cruz)

Agenda

5:00pm - 5:05pm Welcome Remarks - GlobalSF

5:05pm - 5:10pm Opening Remarks -  Enterprise Singapore, and City & County of San Francisco

5:10pm - 5:15pm Panel Discussion Commences - GlobalSF Introduces speakers

5:15pm - 5:45pm Moderated Discussion with Lucence Diagnostics, Engine Biosciences & QB3

5:50pm - 6:00pm Q&A and End of Program 

Our Sponsors